A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods

Clinical trial NCT05585398 · COMPLETED

Trial details

NCT number: NCT05585398
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

N/A, as no Specific Medical Condition Will be Treated

Start date: 2022-10-19
Primary completion: 2023-02-24
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.